Podcasts about Phreesia

Managing and acting on social determinants of health data can be a difficult task for providers with limited resources, but digital tools are helping them address health equity, says Dr. Hilary Hatch, chief clinical officer at Phreesia.

Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Hillary Hatch, Chief Clinical Officer at Phreesia.What you'll get out of this episode:Hilary Hatch's Role: As Phreesia's Chief Clinical Officer, Hilary Hatch leverages her background in clinical psychology to enhance patient readiness and engagement.Digital Check-In Solutions: Phreesia is renowned for its digital check-in systems, facilitating over 150 million patient visits per year, streamlining the check-in process, and preparing patients for their healthcare appointments.Impact of COVID-19: Hatch notes significant setbacks in preventive care due to the pandemic, emphasizing the need for efficient healthcare strategies to manage patient care post-COVID.Innovative Patient Care Tools: Phreesia utilizes technology such as personalized messaging and the patient activation measure to improve health outcomes and streamline care.Focus on Medication Adherence: A new initiative by Phreesia aims to ensure patients follow through with prescriptions, addressing barriers such as cost and awareness.To learn more about Phreesia:Website https://www.phreesia.com/ LinkedIn https://www.linkedin.com/company/phreesia/ Guest's Socials:LinkedIn https://www.linkedin.com/in/hilary-hatch-ph-d-bb022577/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Presenting patients with high-quality, relevant information at meaningful times has significant benefits, including helping them have important provider conversations and make decisions about their health. But responsible data collection and use is critical to maintaining patients' trust. This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Tercera hora de Visión Global que dedicamos a nuestro consultorio de Wall Street en el que nos acompaña Pepe Baynat de Bolsas y Futuros. Con él analizamos compañías como Lockheed Martin, Cazoo, Walmart, Logitech, District Metals, Estee Lauder, Zebra Tecnologies, Upstart Holdings, Phreesia, AMD. Después, último repaso a la actualidad de los mercados y repasamos titulares empresariales con Paloma Arnaldos y María de la Cerca. Terminamos con el repaso de los mercados en el que nos acompaña Joaquín Robles, analista de XTB. Con él comentamos los mensajes que han lanzado los miembros de la Reserva Federal. Y es que hoy hemos podido escuchar la palabras de Michelle Bowman, Mary Daily y Loretta Mester. También hablamos de los máximos históricos que volvemos a observar en la cotización del oro y también miramos las intensas subidas del precio del petróleo con el Brent y el West Texas avanzando una jornada más más de un 1%.

Naveen Chadalavada brings his operational mindset and experience leading teams to business problems at hand. While he is currently leading a team at Phreesia who grows and nurtures partnerships, he has had a variety of experience both in and out of the classroom across the provider healthcare space. From his days in consulting to his time in the technology space, Naveen has focused much of his professional career on building a foundational toolkit to help him set up to be a leader in the healthcare industry. Naveen enjoys meeting new people, learning about their passions, and fostering collaborative networks. During his free time, you will likely catch him at a sporting event or spending time with his family. Naveen has a master's degree in business from the Kellogg School of Management and a master's degree in public health from George Washington University. These experiences provide an academic complement to his professional experiences in the field.

Historically marginalized groups often face barriers to accessing healthcare, from cultural and language differences to economic and geographic disadvantages. And because of these barriers, patients in these communities don't always get the health content, resources and support they need. Effectively reaching and activating these patients to participate in healthcare decision-making requires a concerted effort not only to tailor content so that it resonates with their experiences, but also to remove barriers to education and access. This podcast will explore strategies that can move the needle and improve health equity for patients in underserved communities. 

Alex Rosenblat is particularly careful when it comes to her digital privacy. She requests to fill out paper forms instead of digital ones; she documents and tracks what she signs. But even her diligence can't always save her. Rosenblat recently spent months retracing her digital steps after Phreesia, a company that collects demographic information, claimed to have her authorization to share her data — authorization she knew she hadn't consented to. This week, Rosenblat talks to host and editor Torie Bosch about tracking down her own information and the amorphous harm caused by invasions of privacy.

What you'll get out of this episodeListen in as host Tim Fitzpatrick chats with Adeline Dorough about the importance of patient reported outcomes (PROs) including the Patient Activation Measure (PAM). The “PAM” has been highlighted as a key variable in more than 750 peer-reviewed studies to date. Adeline teaches us that while high-quality medical care is an important determinant of health outcomes, patients' health behaviors play a large role, too. By leveraging patient activation to gauge an individual's ability to manage their own health and take an active role in their care, care teams can be better equipped to provide high-quality care that meets a patient's individual needs.In this episode you'll discover: Patient activation refers to an individual's ability to manage their own health and take an active role in their care. At its core, the concept of patient activation stems from one underlying question: Does this patient possess the knowledge, skills and confidence to manage their own health and healthcare? A patient-reported outcome (PRO) is a report of a person's health status that comes directly from the patient. Patient-reported outcomes are important because so many diagnoses cannot be made by a lab test or imaging. In many ways, PROs capture health data that are invisible in the standard of care, but essential to how we deliver high quality-care. Why the PAM is the gold standard tool for assessing patient activation, and is endorsed by the National Quality Forum (NQF). How Phreesia partners with companies to give patients the tools they need to take an active role in their care.  How patients move between PAM levels during their care journeys, and why that matters. Clinicians can use the PAM levels to understand where each person may need a little more support and modify their approach to care delivery. Quotables“By leveraging PROs and our work at Phreesia, we are able to better understand how to help patients and meet them where they are in their individual healthcare journey; and beyond that, we are able to help clinicians and staff as well, because we are electronically administering these PRO measures before they even step foot into the office. That means providers can spend time understanding that information and then using the appointment time to really get into the meat of it. “@AgileAdeline #Phreesia on Ep30 @T-Minus10 w/ @trfitzpatrickRecommended Resources Development of the Patient Activation Measure (PAM) 10 Strategies to Increase Patient Activation (Phreesia Blog) White Paper: The key to reducing no-shows? Patient engagement (Phreesia) Join the Conversation PhreesiaAdeline Dorough on LinkedIn“This is a beautiful infographic and the content is often underappreciated. Dr. Murdoch's quote is insightful and true, “Often, the ‘oh by the way' comments are the biggest thing.” Thanks for sharing Dr. Maida Affan!” Adeline on LinkedInAbout Your HostTim Fitzpatrick is the CEO of IKONA Health, a company using neurobiology and immersive technology to improve how patients learn about their care and treatment options. Tim co-founded IKONA based on his own patient experiences while serving in the US Navy and now in the VA health system. He has served as Principal Investigator on multiple federal research grants, has co-authored papers on learning science, VR, and mental health in the age of COVID-19, and has partnered with top healthcare investors and institutions including the National Science Foundation, Department of Defense, National Artificial Intelligence Institute, StartUp Health, On Deck, FundRx, MATTER and NVIDIA.T-Minus 10 is a part of the Slice of Healthcare podcast network. 

You ever have a doctor take photos of your condition for further examination? How about an MRI? Have you had one of those? We like to think that HIPPA (Health Insurance Portability and Accountability Act) protects us here in the US. But increasingly ... It doesn't.So over the next few weeks, we'll talk about who's collecting your medical information, how they're using it, and who they're sharing it with. And this series is wild because we're not only talking about pictures of that funny-looking mole you have. We're talking about the neural patterns of your brain and how it acts as you make decisions in Virtual Reality.First things first, though: This week, we're going to look at services like MyChart, Phreesia, and the MANY doctor's offices that utilize Facebook's Tracking Pixel on their website. We'll tell you how to stop these companies from collecting and sharing your data, and then we'll explain why you want to do that. I mean, unless you want a generative AI like Chat GPT3 to be looking at photos of your favorite private parts and drawing some really interesting conclusions to share with others. (A real thing that's already happened.)Also, In Today's Episode ...BJ Speaks with Matthew D Green at John Hopkins University Information Security Institute to follow up on our previous episode concerning "The Cloud" and why you shouldn't put your important stuff in there.Resources Mentioned In Today's Show-Email Privacy@Phreesia.com to opt out of their data collection -Call your doctor's office to see what data is being shared and collected on you by companies like My Chart and request to opt out.-Use the Tor Browser when visiting any websites related to managing your health care.-Use PimEyes to see who is using pictures of your face.-Use the pictures found by PimEyes to search HaveIBeenTrained.com to make sure your photos aren't being used to train generative AIs like ChatGPT3 -Request Clearview AI remove any pictures they have on you here.-BJMendelson.com's Data Opt-Out Request ListOur Sponsor: DuckDuckGo*Affiliate Link: 1Password.com *Affiliate Link: Delete MeGet Your Privacy Notebook: Get your Leuchtturm1917 Official Bullet Journal here.*Using these affiliate links helps to support the show and do not cost you anything extra to use. If you like the show, we encourage you to use these links to sign-up for must have services like 1Password and Delete Me.And before we go ...Thanks to the interview in Slate, we're overwhelmed with requests for Privacy Audits.So!We want to let you know BJ and Amanda are recording a two-hour video course that you can purchase.The course will include every step from the privacy audit and examples of how to put those steps into practice.If you'd like to know when the course is available, email BJ at BJMendelson@Duck.com with Privacy Course in the subject line. 

In this episode we are joined by Michael Rasbury, Senior Director, Client Solutions, at Phreesia, to discuss why healthcare organizations should prioritize high-quality service and support when evaluating technology vendors. Michael discusses the key considerations that leaders should keep in mind when evaluating vendor capabilities and what healthcare organizations should expect from their major technology vendorsThis episode is sponsored by Phreesia.

Tune into this episode to learn how rural health systems and practices can improve patient engagement without burdening staff. JJ Lane, an Associate Director of Strategic Marketing at Phreesia, discusses how rural healthcare organizations are connecting with their patients to improve care—even while they're faced with unprecedented staffing challenges.This episode is sponsored by Phreesia

Phreesia, Inc., Q2 2023 Earnings Call, Sep 07, 2022

Senior Editor Annalee Armstrong was doing a pretty routine interview with Genentech's Greg Rippon when she heard what she says was a mea culpa. Genentech wasn't able to recruit the kind of diverse population that would truly reflect the predominance of Alzheimer's in non-white communities. Annalee will discuss what she heard from Rippon about the lack of trial diversity and how Genentech hopes to get it right in the future.  How memorable are diabetes brands? According to a new report out by Phreesia, patients are too overloaded with names to remember. We'll discuss how pharma companies could change their marketing strategy. To learn more about topics in this episode:  Genentech didn't get it right on diversity for critical Graduate Alzheimer's program. They're trying again  Diabetes brand awareness in the doldrums despite plowing big bucks into ad campaigns  Abbott proclaims FDA approval of neurostimulator to treat pain in 6 areas at once  After FDA rejection, Gilead's long-acting HIV med Sunlenca snags first global nod  Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab  Alcon swoops on Aerie, striking $770M buyout to expand eye drug pipeline  Ex-Novartis unit Alcon keeps eye med expansion rolling with $770M pact to snap up Aerie  Alcon scopes out $475M acquisition of glaucoma stent maker Ivantis UPDATED: Teva won't reopen troubled California site, where 300-plus are losing their jobs  We're looking for 2022's Fiercest Women in Life Sciences—closes this week  The Top Line is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts. See omnystudio.com/listener for privacy information.

In this episode, we connect with Dr. Christina Suh, a Director of Clinical Content at Phreesia. Tune in and learn about the benefit of screening patients digitally, when children should be screened for behavioral and developmental disorders, and how pediatricians can help reduce gun-related injuries.This episode is sponsored by Phreesia

Chaim Indig, CEO of Phreesia, speaks with Dan and Adam about the needs and preferences with technology that patients require to become “activated.” Chaim explains how on average, 86% of patients are comfortable with today's technology. They are wanting to handle their own admin work and want to spend even more time with their clinicians. “Patients are the center of healthcare, so their voices matter,” says Indig. The activated patient is the easiest to treat because they are willing to take their health into their own self. Ingid mentions that the challenge is on how to move patients from one level to the next to allow them more time with clinicians.

In this episode, we are joined by Jennifer Sisto Gall, MPH, Director of Policy and Clinical Programs at Phreesia, to discuss the effect that healthcare policy has on health equity. Tune in to learn how changes at the federal and state level are influencing how payers and providers address health disparities, and gain strategies for how your healthcare organization should be investing resources.This episode is sponsored by Phreesia.

In this episode, we are joined by Hilary Hatch, PhD, Chief Clinical Officer at Phreesia, to discuss how collecting patient-reported data on race, ethnicity and language improves care and advances health equity. Learn how Phreesia can help your organization streamline the collection of demographic data, patient-reported outcomes and more.This episode is sponsored by Phreesia.

This podcast, which was initially recorded as a panel discussion on Digital Health Innovation, has been created by the Montefiore Einstein Innovation Biodesign Training Program. Link - https://einsteinmed.edu/departments/medicine/innovation/biodesign-training/ The podcast's host is Dr. Sunit Jariwala, an Associate Professor of Medicine and Director of Clinical & Research Innovation at Montefiore Einstein. Dr. Jariwala is the Director of Research within the Division of Allergy and Immunology at the Albert Einstein College of Medicine. This podcast's guest presenters – Marc Gibber, MD. Associate Professor, Department of Otolaryngology/Head and Neck Surgery, Montefiore Health System. Co-Founder, Sigma Surgical Hilary Hatch, PhD. Vice President of Clinical Engagement, Phreesia. CEO and Founder, Vital Score Girish Nadkarni, MD. Associate Professor (Medicine/Nephrology) and Clinical Director, Charles Bronfman Institute of Personalized Medicine, Mount Sinai Health System. Scientific Co-Founder, Renalytix AI

Eric goes one-on-one with Chris Delaney, Founder, and CEO of Insignia Health. During the episode, Chris talks about consumer centricity and the importance of the patient activation measure (PAM) for health plans and providers. He provides various case studies and overall guidance on how to successfully implement activation programs that work. This episode is sponsored by Insignia Health Insignia Health provides the only empirically derived and quantifiable model for healthcare organizations, professionals and consumers to co-create personalized healthcare strategies to improve health self-management. By continuously measuring and increasing patient activation, our clients empower individuals to unlock their potential, leading to better health outcomes, lower costs and improved well-being. And now, as part of Phreesia, Insignia Health further expands the spectrum of organizations that can leverage patient activation to achieve their strategic objectives and connect with patients before, during and after their healthcare encounters. Their partners include hospitals and health systems, health plans and insurers, pharmaceutical companies and government health programs around the world, including direct contracts with leading healthcare organizations like the Centers for Medicare and Medicaid Services (United States) and the National Health Service (England). In order to improve a consumer's health, we have to meet them where they are. The Patient Activation Measure® (PAM®) is a 10- or 13-item survey that measures a patient's current knowledge, skills and confidence to manage their own health and healthcare. PAM's design and results are validated by hundreds of published studies from researchers around the world. Visit: insigniahealth.com

Phreesia, Inc., Q3 2022 Earnings Call, Dec 09, 2021

Auldyn Matthews is the Associate Director of UX at Phreesia. Phreesia is a platform service provider across Administrative, financial and clinical operations to revolutionize point of service for medical groups of all sizes so they can provide exceptional patient care. Auldyn failed into Design as she always wanted to take the data research she was conducting to the next level. She has some great tips and insights for junior designers to think about as they navigate the design world. Auldyn is super excited about all that is coming up for Phreesia in the coming year and is looking to find good talent as they get ready to launch new and enhanced healthcare products.

In this episode, we are joined by Kristin Roberts, Vice President of Market Development at Phreesia, to discuss how to improve patient access in a staffing crisis. Learn how Phreesia can help you get the most out of your staff and support your patient access needs.This episode is sponsored by Phreesia.

In this episode, we are joined by Dr. Zeeshan Butt, Director of Clinical Content at Phreesia, to discuss patient reported outcomes (PROs) and the patient experience. We'll discuss pitfalls in common ways of collecting and using PROs and ways that technology can help better engage patients and help clinicians provide more comprehensive care. Learn more about how Phreesia supports your PRO needs.This episode is sponsored by Phreesia.

In this episode, we are joined by Kristin Roberts, Vice President of Marketing Development at Phreesia, to discuss how to improve patient access in a staffing crisis.This episode is sponsored by Phreesia.

In this episode, we are joined by Kristin Roberts, Vice President of Market Development at Phreesia, to discuss how to improve patient access in a staffing crisis. Learn how Phreesia can help you get the most out of your staff and support your patient access needs.This episode is sponsored by Phreesia.

In this episode, we are joined by Kristin Roberts, Vice President, Market Development at Phreesia, to discuss how to improve patient access in a staffing crisis. Learn how Phreesia can help you get the most out of your staff and support your patient access needs.This episode is sponsored by Phreesia.

In der heutigen Folge „Alles auf Aktien“ berichten die Finanzjournalisten Anja Ettel und Holger Zschäpitz über das schaurige S-Wort, die Frage, ob AMC wirklich 25 Milliarden Dollar wert sein sollte und über smarte Investments in Mega-Cities. Außerdem geht es um Gold, Match Group, SPDR S&P 500 (WKN: 898706), Pinduoduo, JD.com, Netease, Baidu, ishares Global Infrastructure UCTIS ETF (WKN: A0LEW9), Amundi Smart City ETF (WKN: A2PN7), JMDC, Hisense Home, Phreesia, iRobot. "Alles auf Aktien" ist der tägliche Börsen-Shot aus der WELT-Wirtschaftsredaktion. Die Wirtschafts- und Finanzjournalisten Holger Zschäpitz, Anja Ettel, Philipp Vetter, Daniel Eckert und Nando Sommerfeld diskutieren im Wechsel über die wichtigsten News an den Märkten und das Finanzthema des Tages. Außerdem gibt es jeden Tag eine Inspiration, die das Leben leichter machen soll. In nur zehn Minuten geht es um alles, was man aktuell über Aktien, ETFs, Fonds und erfolgreiche Geldanlage wissen sollte. Für erfahrene Anleger und Neueinsteiger. Montag bis Freitag, ab 5 Uhr morgens. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++Werbung+++ Hier geht's zur App: Scalable Capital ist der Broker mit Flatrate. Unbegrenzt Aktien traden und alle ETFs kostenlos besparen – für nur 2,99 € im Monat, ohne weitere Kosten. Und jetzt ab aufs Parkett, die Scalable App downloaden und loslegen. Hier geht's zur App: https://bit.ly/3abrHQm

Phreesia, Inc., Q2 2022 Earnings Call, Sep 02, 2021

AppLovin CEO Adam Foroughi (APP) tells us about his company's unique acquisition philosophy when it comes to mobile games. Asana (ASAN) tells us that companies are spending a lot on getting organized post-Pandemic. Barnes & Noble Education (BNED) figures out how to sell college textbooks to students even when they aren't returning to campus. Phreesia (PHR) waits on spending on elective surgeries to make a comeback. Walmart (WMT) raises wages. Apple (AAPL) tries to make nice with Spotify (SPOT). The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

Começar a semana com aquela parceria interessante entre Clubhouse e Ted Talks que tal? Dados do IMS coloca o Brasil no décimo lugar como o país com a maior demanda de medicamentos de alta complexidade. Qual a previsão para 2024?A startup Phreesia traz um relatório interessante sobre o PSP, o que os pacientes têm falado já que a Indus Farma gasta 5 bilhões de dólares ano com esse tipo de investimento.Todas as segundas!Acesse o site Aqui ouhttp://bit.ly/tomouep73psp

Today's episode features Dr. Alicia Cowley, hospitalist and Director of Clinical Content at Phreesia, a healthcare technology company that focuses on the patient intake process. Here she talks about how the COVID-19 pandemic has caused millions of people to delay preventive and routine healthcare, and solutions for how to bring them back to the office to get the care they missed. Learn more about how Phreesia can help you address your patients' delayed care. This podcast is sponsored by Phreesia.

Phreesia, Inc., Q1 2022 Earnings Call, Jun 04, 2021

The COVID-19 pandemic has had a major impact on patients' preferences and expectations when it comes to care, and it's accelerated the move toward consumerism. These patient-centric shifts toward convenience, flexibility, personalization and technology-enabled experiences are likely here to stay, and the podcast will explore what these changes mean for healthcare marketers.

This episode features Dr. Christina Suh, MD, MPH, Director of Clinical Content at Phreesia. Here Dr. Suh discusses food insecurity, a growing issue due to the economic impact of the COVID-19 pandemic. She offers key insights on the importance of screening for food insecurity, what options providers have, and much more! Learn how Phreesia can help you screen for food insecurity and other social determinants of health. This episode is sponsored by Phreesia.

This episode features Dr. Christina Suh, Director of Clinical Content at Phreesia. Here Dr. Suh discusses food insecurity, a growing issue due to the economic impact of the COVID-19 pandemic. She offers key insights on the importance of screening for food insecurity, what options providers have, and much more! Learn how Phreesia can help you screen for food insecurity and other social determinants of health. This episode is sponsored by Phreesia.

In this episode of the podcast, Hilary Hatch, PhD, a clinical psychologist and Vice President of Clinical Engagement at Phreesia, discusses vaccine hesitancy and how health systems can use data to improve equitable distribution of the COVID-19 vaccine. Learn how Phreesia is helping health systems increase vaccine uptake and address vaccine hesitancy. This episode is sponsored by Phreesia. Links: Learn how: https://www.phreesia.com/covid-19-vaccine-management/?utm_source=podcast&utm_medium=beckers-podcast&utm_campaign=em-2021-02-25-beckers-podcast-vaccine-hesitancy Phressia: https://www.phreesia.com/

In this episode of the podcast, Hilary Hatch, PhD, a clinical psychologist and Vice President of Clinical Engagement at Phreesia, discusses vaccine hesitancy and how health systems can use data to improve equitable distribution of the COVID-19 vaccine. Learn how Phreesia is helping health systems increase vaccine uptake and address vaccine hesitancy.

Leaders in healthcare are facing a world that is anything but the status quo. In today’s episode, Katie Lawrence, MHA, CMPE, Director, Ambulatory Optimization & Integration, Prisma Health, examines how leaders can address change in their organizations to become more successful in engaging team members, physicians, and other stakeholders. As Katie says, leadership begins with self, and she talks about how leaders can identify their reactions to changes and how to authentically accept those reactions while understanding that others may not view the same change in the same way. Katie she says one great source she often turns to is Dr. Brené Brown, a research professor who has spent the past two decades studying courage, vulnerability, shame, and empathy. You can learn more about her teachings at https://brenebrown.com. Thanks to Sarepta Therapeutics and to Phreesia for sponsoring this week’s show. Read a new white paper from Sarepta Therapeutics at mgma.com/sarepta. And to find out how Phreesia’s contactless intake workflows are helping practices eliminate the waiting room, visit https://bit.ly/3lm05MV. ​If you like the show, please rate and review it wherever you get your podcasts. If you have topics you'd like us to cover or experts you'd like us to interview, email us at podcasts@mgma.com, or reach out to MGMA Sr. Editor and MGMA Insights podcast host Daniel Williams on Twitter at twitter.com/MGMADaniel. MGMA Insights is presented by Decklan McGee, Rob Ketcham and Daniel Williams.

Phreesia's David Linetsky reveals how the point-of-care space adapted its offerings for the coronavirus era in this week's episode of The MM&M Podcast.

Mental Health Market Update: 7/17/2020 – 2Q 2020 Disruptive Healthcare Earnings Preview – With 2nd Quarter 2020 earnings announcements just around the corner, I thought it would make sense to take stock of where our disruptive healthcare peers are trading, how they have performed so far this year and what to expect and watch out for as their release earnings in the coming weeks. In today’s episode we are focused on a subset of our “Disruptive Healthcare” peers which as a group broadly, includes Teladoc, Livongo, One Medical, Health Equity, Progyny, Health Catalyst, Phreesia, Ontrak (which was Catasys prior to this week but they changed their name as you’re aware). In this episode we digest what startups and their investors in the digital health space should be focused on, what those bits of information mean and what we can take away from how these companies are performing as well as what they report by way of Q2 earnings. LINKS REFERENCED IN THE SHOW: Livongo earnings call details: 8/6, Dial-in 270-215-9499; ID: Livongo One Medical earnings call details: Date: TBD; Dial-in: TBD Teladoc earnings call details: 7/29 at 4:30pm ET, 833-968-2101 Mental Health Startup Community Slack: Link Here   You can support Stigma Podcast and get deeper insights and white papers here on Patreon: https://www.patreon.com/stigmapodcast Connect with the Stigma Podcast in the following ways: Website, Twitter, Facebook, LinkedIn, Email Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)      

This is Investor Perspectives, I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.  In today’s show, you’ll hear about healthcare and its impact on startups. COVID-19 has changed the landscape for startups giving us a new normal. During the pandemic, it became clear the need for changes in our healthcare system. We have joining us, Thomas Hawes of Blue Venture Fund - an investor in the healthcare space.  Tom is a member of the BlueCross BlueShield Fund Management team at Sandbox Industries and serves on the Sandbox Management Committee. He is the Board Chairman for Patientco, serves on the Board of Directors of Verata Health, Upward Health (fka BehaveCare), Octave Bioscience, Oncology Analytics, and AbleTo and is a board observer of HeartFlow, Thrive Earlier Detection, Phreesia, and Healthify. Tom holds a BA from Brigham Young University, an M.D. from New York Medical College, medical residency training at Yale, and an MBA from Harvard Business School. He is also a Kauffman Fellow.  You can visit Blue Venture Fund at . Thomas can be contacted via LinkedIn at , via Twitter at , and via email at . I hope you enjoy this episode.

Here, Scott Becker talks with Chaim Indig, the CEO of Phreesia, about how the company is working to support healthcare providers during the COVID-19 pandemic and how the crisis is likely to influence the way care is provided long after the virus abates. This podcast is sponsored by Phreesia.

This month on Revenue Rebels, Rhoan Morgan sits down with Rebecca Kaufman, Director, Strategic Marketing at Phreesia to discuss the importance of segmentation in marketing.  You wouldn’t market to the CEO of a Fortune 100 company in the same way you’d market to an SMB marketing director. Why market to your customer and prospect audiences in the same way? When you prioritize segmentation, you enable your company to target the right audience with the right message at the right time, while delivering a superior experience. Some of the items discussed are: How to target personas Tools for segmentation strategy Why data is one of a company’s biggest investments Why all company marketing plans start with good data How Phreesia uses segmentation in building a go-to-market plan Why Phreesia uses segmentation to develop marketing campaigns and content Revenue Rebels is hosted by Rhoan Morgan, CEO of DemandLab the host sponsor.   You may also like: How Revenue Operations Improves Customer Engagement Hear the best of Rhoan Morgan here.   ___________________________________________ Revenue Rebels is hosted by Rhoan Morgan of DemandLab which is a program on the Funnel Radio Channel.  DemandLab is the sponsor of Revenue Rebels    

This month on Revenue Rebels, Rhoan Morgan sits down with Rebecca Kaufman, Director, Strategic Marketing at Phreesia to discuss the importance of segmentation in marketing.  You wouldn’t market to the CEO of a Fortune 100 company in the same way you’d market to an SMB marketing director. Why market to your customer and prospect audiences in the same way? When you prioritize segmentation, you enable your company to target the right audience with the right message at the right time, while delivering a superior experience. Some of the items discussed are: How to target personas Tools for segmentation strategy Why data is one of a company’s biggest investments Why all company marketing plans start with good data How Phreesia uses segmentation in building a go-to-market plan Why Phreesia uses segmentation to develop marketing campaigns and content Revenue Rebels is hosted by Rhoan Morgan, CEO of DemandLab the host sponsor.   You may also like: How Revenue Operations Improves Customer Engagement Hear the best of Rhoan Morgan here.   ___________________________________________ Revenue Rebels is hosted by Rhoan Morgan of DemandLab which is a program on the Funnel Radio Channel.  DemandLab is the sponsor of Revenue Rebels    

As patients out-of-pocket costs continue to rise, they’re searching out providers that offer convenience, flexibility, engagement and personalization—consumer-centric features that provide the experience they increasingly prefer and expect. Technology plays a critical role in providing a high-quality healthcare experience not only to patients, but also to staff and clinicians. In this podcast, Phreesia CEO Chaim Indig discusses the industry trends that are reshaping the healthcare experience, the role that the “digital front door” plays in engaging patients, his company’s recent IPO and the keys to Phreesia's fast growth.

On Episode 3 of HardCore Health, Jess & I start off by discussing all of the health tech companies IPOing (Livongo, Phreesia, Health Catalyst) and talk about what that means for the industry as a whole. Zoya Khan discusses the newest series on THCB called, “The Health Data Goldilocks Dilemma: Sharing? Privacy? Both?”, which follows & discuss the legislation being passed on data privacy and protection in Congress today. We also have a great interview with Paul Johnson, CEO of Lemonaid Health, an up-and-coming telehealth platform that works as a one-stop-shop for a virtual doctor's office, a virtual pharmacy, and lab testing for patients accessing their platform. In her WTF Health segment, Jess speaks to Jen Horonjeff, Founder & CEO of Savvy Cooperative, the first patient-owned public benefit co-op that provides an online marketplace for patient insights. And last but not least, Dr. Saurabh Jha directly address AI vendors in health care, stating that their predictive tools are useless and they will not replace doctors just yet- Matthew Holt

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. This was a special week for us because Danny was back in the office, which meant we cornered him into coming on the show. Danny, of course, is an Equity regular. Also aboard this week were our regular hosts, Kate and Alex. We were relieved to have three hosts because there was a lot of news to get through, from IPOs to late-stage financings to little seed fundings, and we shit you not, camping! Up first was the rapidly-approaching WeWork IPO. WeWork, also known as The We Company, filed to go public some time ago. So we weren't terribly surprised to learn the company is plotting a September listing. Though that's earlier than we'd been expecting, we're not complaining. If the sooner-than-anticipated IPO is due to market timing, or the company simply being ready we don't know yet. But we will when we see the numbers. Bring on the S-1 filing. Next Alex took us through a few recent and upcoming IPOs. He promised to be brief, so we'll mirror the feat here. Last week Phreesia, Medallia, and DouYu went public (notes here), Livongo got out this week (S-1 review here), and 9F and CloudMinds have filed. Expect more IPO news in time whether you want it or not. Leaving the public markets, Kate had words concerning the forthcoming Bird round that has yet to close. The company is raising its Series D led by Sequoia at a $2.5 billion valuation. Listen to the episode for your weekly scooter rant. Next, Danny took us through the Robinhood round, which brought us to a discussion point. Alex wanted to compare Robinhood to Slack, when the latter company was worth about the same amount as Robinhood is now. Kate objected to the comparison, one's an enterprise software business and the other a fintech giant. Still, Alex had lots of great points. We then turned to HipCamp. The company, known as Airbnb for camping, raised a nice round of funding at a $127 million valuation. Andreessen Horowitz was involved via new general partner Andrew Chen, who recently announced another deal in the email subscription platform Substack. We're betting Airbnb gobbles up HipCamp at some point. We also touched on Gusto's $200 million raise (and its constituent new valuation), before closing with the now-very-probable Vision Fund 2.0 and its Microsoft connection. All that and we left even more material on the floor due to time. Make sure to check Equity out on Spotify if you haven't seen us over there before. Click here to find the show.

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. This was a special week for us because Danny was back in the office, which meant we cornered him into coming on the show. Danny, of course, is an Equity regular. Also aboard this week were our regular hosts, Kate and Alex. We were relieved to have three hosts because there was a lot of news to get through, from IPOs to late-stage financings to little seed fundings, and we shit you not, camping! Up first was the rapidly-approaching WeWork IPO. WeWork, also known as The We Company, filed to go public some time ago. So we weren't terribly surprised to learn the company is plotting a September listing. Though that's earlier than we'd been expecting, we're not complaining. If the sooner-than-anticipated IPO is due to market timing, or the company simply being ready we don't know yet. But we will when we see the numbers. Bring on the S-1 filing. Next Alex took us through a few recent and upcoming IPOs. He promised to be brief, so we'll mirror the feat here. Last week Phreesia, Medallia, and DouYu went public (notes here), Livongo got out this week (S-1 review here), and 9F and CloudMinds have filed. Expect more IPO news in time whether you want it or not. Leaving the public markets, Kate had words concerning the forthcoming Bird round that has yet to close. The company is raising its Series D led by Sequoia at a $2.5 billion valuation. Listen to the episode for your weekly scooter rant. Next, Danny took us through the Robinhood round, which brought us to a discussion point. Alex wanted to compare Robinhood to Slack, when the latter company was worth about the same amount as Robinhood is now. Kate objected to the comparison, one's an enterprise software business and the other a fintech giant. Still, Alex had lots of great points. We then turned to HipCamp. The company, known as Airbnb for camping, raised a nice round of funding at a $127 million valuation. Andreessen Horowitz was involved via new general partner Andrew Chen, who recently announced another deal in the email subscription platform Substack. We're betting Airbnb gobbles up HipCamp at some point. We also touched on Gusto's $200 million raise (and its constituent new valuation), before closing with the now-very-probable Vision Fund 2.0 and its Microsoft connection. All that and we left even more material on the floor due to time. Make sure to check Equity out on Spotify if you haven't seen us over there before. Click here to find the show.

You wouldn’t market to the CEO of a Fortune 100 company in the same way you’d market to an SMB marketing director. Why market to your customer and prospect audiences in the same way? When you prioritize segmentation, you enable your company to target the right audience with the right message at the right time, while delivering a superior experience. This month on Revenue Rebels, Rhoan Morgan sits down with Rebecca Kaufman, Director, Strategic Marketing at Phreesia to discuss the importance of segmentation in marketing.About Our GuestRebecca Kaufman, Director, Strategic MarketingRebecca Kaufman oversees Phreesia’s marketing plans and top of the funnel strategy. She is responsible for aligning Phreesia’s positioning and messaging with the appropriate segment, offering and stage of the buyer’s journey.Prior to Phreesia, Rebecca managed the New York Medicare advantage market and ACO relationships at Aetna. She also worked in management consulting at Navigant Consulting, helping to improve healthcare provider operations. Rebecca earned an MBA from Columbia Business School and holds a BA in Economics from Washington University in St. Louis.

Product marketing sits at the intersection of product, marketing, and sales, making it a critical function in enhancing value creation for the customer and supporting sales enablement.This month, Kristin Roberts, Vice President, Product Marketing at Phreesia, joins the Revenue Rebels podcast to share strategies on how product marketing can and should deliver value internally and externally. Tune in to find out:How product marketing supports sales enablementProduct marketing’s role in revenue generationWhat technologies support product marketing and sales team collaborationAbout our guest:Kristin Roberts is responsible for the positioning and go-to-market strategy for Phreesia’s products and applications. Before joining Phreesia, Kristin was a management consultant at Booz & Company, where she led product launch and growth strategy engagements for its life sciences clients. She also worked as a consultant at ZS Associates, specializing in quantitative physician market research and sales deployment optimization. Kristin earned an MBA from Columbia Business School and holds a BA in Public Health Studies from Johns Hopkins University.

On this episode, learn about Phreesia, the three time Greenway Health Marketplace Partner of the Year. Phreesia partners with all sizes of healthcare organizations, and integrates with a number of Greenway Health solutions. For more information on the Greenway Health Marketplace, and how Greenway and Phreesia can work with your practice, visit https://www.greenwayhealth.com/marketplace.

In this episode, Steve and Trevor talk with Chaim Indig, CEO of Phreesia.